{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:17:13Z","timestamp":1778887033652,"version":"3.51.4"},"reference-count":68,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T00:00:00Z","timestamp":1440720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"DOI":"10.1371\/journal.pcbi.1004426","type":"journal-article","created":{"date-parts":[[2015,8,28]],"date-time":"2015-08-28T18:43:17Z","timestamp":1440787397000},"page":"e1004426","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":127,"title":["Discovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical Modeling"],"prefix":"10.1371","volume":"11","author":[{"given":"\u00c5smund","family":"Flobak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana\u00efs","family":"Baudot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Remy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liv","family":"Thommesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Thieffry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"L\u00e6greid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,8,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"D Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"B Al-Lazikani","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/nbt.2345","article-title":"Navigating cancer network attractors for tumor-specific therapy","volume":"30","author":"P Creixell","year":"2012","journal-title":"Nat Biotechnol"},{"key":"ref4","first-page":"1","article-title":"Patient-derived models of acquired resistance can identify effective drug combinations for cancer","author":"AS Crystal","year":"2014","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"A a Borisy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/msb.2013.29","article-title":"Network quantification of EGFR signaling unveils potential for targeted combination therapy","volume":"9","author":"B Klinger","year":"2013","journal-title":"Mol Syst Biol"},{"key":"ref7","article-title":"A community computational challenge to predict the activity of pairs of compounds","author":"M Bansal","year":"2014","journal-title":"Nat Biotechnol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1073\/pnas.1311846111","article-title":"High-throughput combinatorial screening identifies drugs that cooperate with ibrutinib to kill activated B-cell-like diffuse large B-cell lymphoma cells","volume":"111","author":"Griner L a Mathews","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"ra85","DOI":"10.1126\/scisignal.2004014","article-title":"Drug Synergy Screen and Network Modeling in Dedifferentiated Liposarcoma Identifies CDK4 and IGF1R as Synergistic Drug Targets","volume":"6","author":"ML Miller","year":"2013","journal-title":"Sci Signal"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1751-0473-3-16","article-title":"Boolean network simulations for life scientists","volume":"3","author":"I Albert","year":"2008","journal-title":"Source Code Biol Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1752-0509-3-1","article-title":"Modeling ERBB receptor-regulated G1\/S transition to find novel targets for de novo trastuzumab resistance","volume":"3","author":"O Sahin","year":"2009","journal-title":"BMC Syst Biol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1000702","DOI":"10.1371\/journal.pcbi.1000702","article-title":"Mathematical modelling of cell-fate decision in response to death receptor engagement","volume":"6","author":"L Calzone","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"055001","DOI":"10.1088\/1478-3975\/9\/5\/055001","article-title":"Boolean modeling in systems biology: an overview of methodology and applications","volume":"9","author":"R-S Wang","year":"2012","journal-title":"Phys Biol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"025114","DOI":"10.1063\/1.4809783","article-title":"Dynamical modeling and analysis of large cellular regulatory networks","volume":"23","author":"D B\u00e9renguier","year":"2013","journal-title":"Chaos"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nrg3885","article-title":"Quantitative and logic modelling of molecular and gene networks","volume":"16","author":"N Le Nov\u00e8re","year":"2015","journal-title":"Nat Rev Genet"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"16308","DOI":"10.1073\/pnas.0806447105","article-title":"Network model of survival signaling in large granular lymphocyte leukemia","volume":"105","author":"R Zhang","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000595","DOI":"10.1371\/journal.pcbi.1000595","article-title":"ON\/OFF and beyond\u2014a boolean model of apoptosis","volume":"5","author":"R Schlatter","year":"2009","journal-title":"PLoS Comput Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e1002267","DOI":"10.1371\/journal.pcbi.1002267","article-title":"Dynamical and Structural Analysis of a T Cell Survival Network Identifies Novel Candidate Therapeutic Targets for Large Granular Lymphocyte Leukemia","volume":"7","author":"A Saadatpour","year":"2011","journal-title":"PLoS Computational Biology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"e18646","DOI":"10.1371\/journal.pone.0018646","article-title":"Modeling the TNF\u03b1-induced apoptosis pathway in hepatocytes","volume":"6","author":"R Schlatter","year":"2011","journal-title":"PLoS One"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1752-0509-6-125","article-title":"Dynamics of p53 and NF-\u03baB regulation in response to DNA damage and identification of target proteins suitable for therapeutic intervention","volume":"6","author":"R Poltz","year":"2012","journal-title":"BMC Systems Biology"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e1003286","DOI":"10.1371\/journal.pcbi.1003286","article-title":"Integrative Modelling of the Influence of MAPK Network on Cancer Cell Fate Decision","volume":"9","author":"L Grieco","year":"2013","journal-title":"PLoS Computational Biology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e69008","DOI":"10.1371\/journal.pone.0069008","article-title":"Boolean network model for cancer pathways: predicting carcinogenesis and targeted therapy outcomes","volume":"8","author":"HF Fumi\u00e3","year":"2013","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/1752-0509-8-75","article-title":"Boolean ErbB network reconstructions and perturbation simulations reveal individual drug response in different breast cancer cell lines","volume":"8","author":"S Von der Heyde","year":"2014","journal-title":"BMC Syst Biol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"SA Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nature11003","article-title":"The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity","volume":"483","author":"J Barretina","year":"2012","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.tcs.2010.10.021","article-title":"Dynamically consistent reduction of logical regulatory graphs","volume":"412","author":"A Naldi","year":"2011","journal-title":"Theoretical Computer Science"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"D955","DOI":"10.1093\/nar\/gks1111","article-title":"Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells","volume":"41","author":"W Yang","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"ref28","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"S Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"T-C Chou","year":"1984","journal-title":"Adv Enzyme Regul"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1038\/sj.onc.1206321","article-title":"Effects of the RAF\/MEK\/ERK and PI3K\/AKT signal transduction pathways on the abrogation of cytokine-dependence and prevention of apoptosis in hematopoietic cells","volume":"22","author":"JG Shelton","year":"2003","journal-title":"Oncogene"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1158\/0008-5472.CAN-10-0460","article-title":"Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis","volume":"70","author":"S Iadevaia","year":"2010","journal-title":"Cancer Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e14124","DOI":"10.1371\/journal.pone.0014124","article-title":"Combination treatment with MEK and AKT inhibitors is more effective than each drug alone in human non-small cell lung cancer in vitro and in vivo","volume":"5","author":"J Meng","year":"2010","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1158\/1078-0432.CCR-11-2683","article-title":"Inhibition of MEK and PI3K\/mTOR suppresses tumor growth but does not cause tumor regression in patient-derived xenografts of RAS-mutant colorectal carcinomas","volume":"18","author":"G Migliardi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.jss.2013.03.052","article-title":"Synergistic inhibition of thyroid cancer by suppressing MAPK\/PI3K\/AKT pathways","volume":"184","author":"E Kandil","year":"2013","journal-title":"J Surg Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrm3507","article-title":"FOXOs: signalling integrators for homeostasis maintenance","volume":"14","author":"A Eijkelenboom","year":"2013","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-2187-3-7","article-title":"Inhibition of PI3K\/AKT and MEK\/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor","volume":"3","author":"S Shankar","year":"2008","journal-title":"J Mol Signal"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"JSC Arthur","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1074\/jbc.M110.101824","article-title":"Regulation of FOXO1 by TAK1-Nemo-like kinase pathway","volume":"285","author":"S Kim","year":"2010","journal-title":"J Biol Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrc3539","article-title":"Forkhead box proteins: tuning forks for transcriptional harmony","volume":"13","author":"EW-F Lam","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"J Leh\u00e1r","year":"2009","journal-title":"Nat Biotechnol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e00747","DOI":"10.7554\/eLife.00747","article-title":"Evolutionary dynamics of cancer in response to targeted combination therapy","volume":"2","author":"I Bozic","year":"2013","journal-title":"eLife"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"5160","DOI":"10.1158\/1078-0432.CCR-12-2408","article-title":"The promise of patient-derived xenografts: the best laid plans of mice and men","volume":"18","author":"S Kopetz","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1158\/0008-5472.CAN-13-2971","article-title":"Cancer cell lines for drug discovery and development","volume":"74","author":"JL Wilding","year":"2014","journal-title":"Cancer Research"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/1078-0432.CCR-13-3047","article-title":"Integrated next-generation sequencing and avatar mouse models for personalized cancer treatment","volume":"20","author":"E Garralda","year":"2014","journal-title":"Clin Cancer Res"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1038\/ng.2762","article-title":"Emerging landscape of oncogenic signatures across human cancers","volume":"45","author":"G Ciriello","year":"2013","journal-title":"Nat Genet"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"AJ Bass","year":"2014","journal-title":"Nature"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.03.031","article-title":"Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks","volume":"149","author":"MJ Lee","year":"2012","journal-title":"Cell"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"E170","DOI":"10.1073\/pnas.1210419110","article-title":"Defining principles of combination drug mechanisms of action","volume":"110","author":"JR Pritchard","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/1752-0509-3-88","article-title":"The crosstalk between EGF, IGF, and Insulin cell signaling pathways\u2014computational and experimental analysis","volume":"3","author":"R Zielinski","year":"2009","journal-title":"BMC Syst Biol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jtbi.2010.03.025","article-title":"Receptor cross-talk in angiogenesis: mapping environmental cues to cell phenotype using a stochastic, Boolean signaling network model","volume":"264","author":"AL Bauer","year":"2010","journal-title":"J Theor Biol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"i495","DOI":"10.1093\/bioinformatics\/bts410","article-title":"Boolean approach to signalling pathway modelling in HGF-induced keratinocyte migration","volume":"28","author":"A Singh","year":"2012","journal-title":"Bioinformatics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1038\/msb.2008.53","article-title":"Models from experiments: combinatorial drug perturbations of cancer cells","volume":"4","author":"S Nelander","year":"2008","journal-title":"Mol Syst Biol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0031-6997(25)06847-4","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"WR Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1752-0509-3-98","article-title":"Transforming Boolean models to continuous models: methodology and application to T-cell receptor signaling","volume":"3","author":"DM Wittmann","year":"2009","journal-title":"BMC Syst Biol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"e1000676","DOI":"10.1371\/journal.pgen.1000676","article-title":"Oncogenic pathway combinations predict clinical prognosis in gastric cancer","volume":"5","author":"CH Ooi","year":"2009","journal-title":"PLoS Genet"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.gastro.2011.04.042","article-title":"Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy","volume":"141","author":"IB Tan","year":"2011","journal-title":"Gastroenterology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nrclinonc.2013.170","article-title":"Gastric cancer-molecular and clinical dimensions","volume":"10","author":"R Wadhwa","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3748\/wjg.v20.i7.1635","article-title":"Treatment of gastric cancer","volume":"20","author":"M Orditura","year":"2014","journal-title":"World J Gastroenterol"},{"key":"ref59","unstructured":"See for instance clinical trials NCT01347866, NCT01363232, NCT01337765 and NCT00996892 (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/\" xlink:type=\"simple\">https:\/\/www.clinicaltrials.gov\/<\/ext-link>)."},{"key":"ref60","unstructured":"See for instance clinical trials NCT01476137, NCT01138085, NCT01907815 and NCT01333475 (<ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.clinicaltrials.gov\/\" xlink:type=\"simple\">https:\/\/www.clinicaltrials.gov\/<\/ext-link>)."},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-5193(05)80350-9","article-title":"Regulatory networks seen as asynchronous automata: A logical description","volume":"153","author":"R Thomas","year":"1991","journal-title":"Journal of Theoretical Biology"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"H Clevers","year":"2012","journal-title":"Cell"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1016\/j.cellsig.2006.02.014","article-title":"IKKalpha stabilizes cytosolic beta-catenin by inhibiting both canonical and non-canonical degradation pathways","volume":"18","author":"N Carayol","year":"2006","journal-title":"Cell Signal"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.2065","article-title":"Crosstalk in NF-\u03baB signaling pathways","volume":"12","author":"A Oeckinghaus","year":"2011","journal-title":"Nat Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/1471-2407-9-198","article-title":"A novel method, digital genome scanning detects KRAS gene amplification in gastric cancers: involvement of overexpressed wild-type KRAS in downstream signaling and cancer cell growth","volume":"9","author":"H Mita","year":"2009","journal-title":"BMC Cancer"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1038\/onc.2010.475","article-title":"Aaronson S a. Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells","volume":"30","author":"S Asciutti","year":"2011","journal-title":"Oncogene"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.biosystems.2009.04.008","article-title":"Logical modelling of regulatory networks with GINsim 2.3","volume":"97","author":"A Naldi","year":"2009","journal-title":"Biosystems"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"T-C Chou","year":"2006","journal-title":"Pharmacol Rev"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pcbi.1004426","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T08:00:01Z","timestamp":1748592001000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1004426"}},"subtitle":[],"editor":[{"given":"Ioannis","family":"Xenarios","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,28]]},"references-count":68,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1004426","relation":{},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,28]]}}}